Current IMF Advocacy Priorities (https://www.myeloma.org/current-imf-advocacy-priorities)
Current IMF Advocacy Priorities
In 2024 and 2025, the International Myeloma Foundation's Advocacy pillar is focused on the following priorities:
1. Ensure Access to Care
Insurance Reform: Drug Access
- Step Therapy Protocols
- Safe Step Act
- PBM Reform
- PBM Reform Act
Medicare Reform: Physician Access
- Tele-Health/Medicine
- Telehealth Modern Act
2. Eliminate Financial Barriers
Insurance Reform: Co-Insurance
- Oral Parity
- Cancer Drug Parity Act
Insurance Reform: Co-Pays
- Copay Accumulator
- HELP Copays Act
Medicare Reform: Annual Cost Limits
- Inflation Reduction Act implementation
- Cap & Smoothing (MPPP)
- Drug Pricing
3. Secure Research Funding
Federal Funding: Annual Appropriations
- NIH: National Cancer Institute
- National Institute on Minority Health
- ARPA-H
- CDC: Comprehensive Cancer Control Initiative
- DoD: Congressionally Directed Medical Research Program (CDMRP) for Myeloma
Clinical Trial Diversity
We focus on
- Underserved populations
- People of color (POC)
- People in rural settings
- Socioeconomically disadvantaged groups
ORAL PARITY
CIACC
The Coalition to Improve Access to Cancer Care (CIACC) ensures patients have access to the treatments that are recommended by their physicians through the oral chemotherapy parity legislation around the country. We’re thrilled to inform you that 43 states and the District of Columbia have passed these critical laws to increase access to oral oncology drugs that are crucial to patient survival. Visit CIACC to learn more.
Display paragraphs below sidebar menu
Off